Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-12
1992-08-25
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514271, 544299, 544301, 544302, 544306, C07D23902, A01N 4354
Patent
active
051419432
ABSTRACT:
5-benzyl barbiturate compounds for use as water-soluble uridine phosphorylase inhibitors are disclosed. These compounds are useful for reducing the toxicity and anemia induced by antiviral drugs such as AZT, as well as for potentiating anticancer drugs and combatting their host-toxicity.
REFERENCES:
patent: 3282921 (1966-11-01), Verheyden et al.
patent: 3687931 (1972-08-01), Verheyden et al.
patent: 3755295 (1973-08-01), Verheyden et al.
patent: 3775397 (1973-11-01), Etzold et al.
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4071680 (1978-01-01), Cook
patent: 4093715 (1978-06-01), Lin et al.
patent: 4128639 (1978-12-01), Lin et al.
patent: 4210638 (1980-07-01), Greer
patent: 4230698 (1980-10-01), Bobek et al.
patent: 4331662 (1982-05-01), Eckstein et al.
patent: 4604382 (1986-08-01), Lin et al.
patent: 4681933 (1987-07-01), Chu et al.
Naguib et al., "Biochemical Pharmacology", 39(13) 2195-2201, 1987.
D'Yachkov et al., Chemical Abstract vol. 87, #200589g 1977, p. 648.
Niedzwicki et al., paper, vol. 32 Biochemical Pharmacology, pp. 339-415 1983.
Goodman and Gilman's The Pharmacological Basis of Therapeutics (1990).
Sommadossi et al., Antimicrobial Agents and Chemotherapy, vol. 32, No. 7, pp. 997-1001 (Jul. 1988), Uridine Reverse . . . .
Horwitz, vol. 29, J. Org. Chem., pp. 2076-2078 (1964), Nucleosides. V. The Monomesylates . . . .
Lin et al., vol. 21, J. Med. Chem., pp. 109-112 (1978), Synthesis and Biological Activity . . . .
Lin et al., vol. 36, Biochem. Pharmacol., pp. 311-316 (1987), Antiviral Activity of . . . .
Schinazi et al., Interscience Conference on Antimicrobial Agents and Chemotherapy Abstract #369 (1987), Selective In Vitro . . . .
Tatsumi et al., Jpn. J. Caner Research (Gann), vol. 78, pp. 748-755 (Jul. 1987), Inhibitory Effects of . . . .
Dyschinsky et al., vol. 79, J. Amer. Chem. Soc., pp. 4559-4560 (1957).
Heidelberg in Antineoplastic and Immune . . . (Sartorelli et al., ed.s, Spinger-Verlag, Heidelberg, pp. 193-231 (1975)).
Niedzwicki et al., vol. 31, Biochemical Pharmacology, No. 10, pp. 1857-1861 (1982), 5-Benzylacyclouridine and . . . .
Monks et al., vol. 32, Biochemical Pharmacology, No. 13, pp. 2003-2009 (1983), Effect of 5-Benzylacyclouridine . . . .
Darnowski et al., vol. 45, Cancer Research, pp. 5364-5368 (1985), Tissue-specific Enhancement . . . .
Naquib et al., vol. 36, Biochemical Pharmacology, No. 13, pp. 2195-2201 (1987), New Analogues of . . . .
Conrad et al., vol. 34 Ber., pp. 1339-1346 (1901), Condensation von . . . .
Sekiya et al., vol. 17, Chem. Pharm., Bull., pp. 738-746 (1969), Formic Acid Reduction . . . .
Speer et al., vol. 21, Org. Syn., pp. 5-8 (1941).
Sekiya et al., vol. 17, Chem. Pharma., Bull., pp. 747-751 (1969), Formic Acid Reduction IV . . . .
Tanaka et al., vol. 36, Chem. Pharm., Bull., pp. 60-69 (1988), 5-Arylidene 1,3-. . . .
Robins et al., vol. 60, Can. J. Chem., pp. 547-553 (1982), Nucleic Acid Related . . . .
Levine et al., vol. 19, Biochemistry, pp. 4993-4999 (1980), Inhibition of Orotidine-5'. . . .
Harnden et al., vol. 4, pp., Nucleosides and Nucleotides, pp. 465 476, (1985) Synthesis of Analogues . . . .
MarCoss et al., vol. 26, Chem. Scripta, pp. 113-121 (1986), Synthetic, Biochemical and . . . .
Kim et al., Chem. Lett., pp. 1045-1048, (1988), Efficient Synthesis of . . . .
Pelter et al., vol. 3, Comprehensive Org. Chem., pp. 760-772 (D. N. Jones ed., Pergamon Press (1976)).
Boss et al., vol. 15, Agnew Chem. Inter. Ed. Engl., pp. 558-559 (1976).
Bayley et al., Tetrahedron Lett., No. 39, pp. 3633-3634 (1978), A Selective Reagent . . . .
Rolla, vol. 47, Org. Chem., pp. 4327-4329 (1982), Sodium Borohydride Reactions . . . .
Chu et al., vol. 24, J. Heterocyclic Chem., pp. 1651-1656 (1986), Synthesis of Variants of . . . .
Bradford, vol. 72, Analyt. Biochem., pp. 248-254 (1976), A Rapid and Sensitive . . . .
Griffith, vol. 55, Ann. Rev. of Biochem., pp. 866-868 (1986).
Hammer et al., vol. 31, Antimicrobial Agents and Chemotherapy, pp. 1046-1050 (1987) Synergistic Activity of . . . .
Cha Sungman
el Kouni Mahmoud H.
Naguib Fardos N. M.
Panzica Raymond
Brown University Research Foundation
Engellenner Thomas J.
Gupta Y. N.
Shah Mukund J.
LandOfFree
5-benzyl barbiturate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-benzyl barbiturate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-benzyl barbiturate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385222